Evidence map›Paper›PMID 38263987›Full record

ArticleObesity science & practice2024

Adipose triglyceride lipase gene expression in peripheral blood mononuclear cells of subjects with obesity and its association with insulin resistance, inflammation and lipid accumulation in liver.

Samira Ezzati-Mobaser, Sahar Yarahmadi, Nikta Dadkhah Nikroo, Mohammad Hasan Maleki, Zeynab Yousefi, Pegah Golpour, Mona Nourbakhsh, Mitra Nourbakhsh

Abstract read
In one paragraph

Article in Obesity science & practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Samira Ezzati-MobaserFinetech in Medicine Research Center Iran University of Medical Sciences Tehran Iran.
Sahar YarahmadiDepartment of Biochemistry Faculty of Medicine Iran University of Medical Sciences Tehran Iran.
Nikta Dadkhah NikrooMetabolic Disorders Research Center Endocrinology and Metabolism Molecular-Cellular Sciences Institute Tehran University of Medical Sciences Tehran Iran.
Mohammad Hasan MalekiDepartment of Biochemistry School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Zeynab YousefiDepartment of Clinical Biochemistry Faculty of Medical Sciences Tarbiat Modares University Tehran Iran.
Pegah GolpourDepartment of Biochemistry Faculty of Medicine Shahid Sadoughi University of Medical Sciences Tehran Iran.
Mona NourbakhshHazrat Aliasghar Hospital School of Medicine Iran University of Medical Sciences Tehran Iran.
Mitra NourbakhshFinetech in Medicine Research Center Iran University of Medical Sciences Tehran Iran.ORCID https://orcid.org/0000-0002-6716-0354

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Adipose triglyceride lipase (ATGL) is a crucial enzyme responsible for the release of fatty acids from various tissues. The expression of ATGL is regulated by insulin and this enzyme is linked to Insulin resistance (IR). On the other hand, ATGL-mediated lipolysis is connected to macrophage function and thus, ATGL is involved in inflammation and the pathogenesis of lipid-related disorders. This study aimed to investigate the correlation between ATGL, obesity, Metabolic Syndrome (MetS), and inflammation. Methods: A total of 100 participants, including 50 individuals with obesity and 50 healthy participants, were recruited for this study and underwent comprehensive clinical evaluations. Blood samples were collected to measure plasma lipid profiles, glycemic indices, and liver function tests. Additionally, peripheral blood mononuclear cells (PBMCs) were isolated and used for the assessment of the gene expression of ATGL, using real-time PCR. Furthermore, PBMCs were cultured and exposed to lipopolysaccharides (LPS) with simultaneous ATGL inhibition, and the gene expression of inflammatory cytokines, along with the secretion of prostaglandin E2 (PGE2), were measured. Results: The gene expression of ATGL was significantly elevated in PBMCs obtained from participants with obesity and was particularly higher in those diagnosed with MetS. It exhibited a correlation with insulin levels and Homeostatic Model Assessment for IR (HOMA-IR), and it was associated with lipid accumulation in the liver. Stimulation with LPS increased ATGL expression in PBMCs, while inhibition of ATGL attenuated the inflammatory responses induced by LPS. Conclusions: Obesity and MetS were associated with dysregulation of ATGL. ATGL might play a role in the upregulation of inflammatory cytokines and act as a significant contributor to the development of metabolic abnormalities related to obesity.

Indexed as

adipose triglyceride lipaseinflammationmetabolic syndromenon‐alcoholic fatty liver diseaseobesity

Identifiers

PMID38263987
PMCPMC10804332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.